Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leht 1 alates 17 tulemused
Method and compositions for treating tumors having high tyrosinase activity
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention is directed to methods and compositions for treating tumors and other metastatic diseases exhibiting high tyrosinase and saccharide enzyme activity. The invention is further directed to methods and compositions for treating tumors having high tyrosinase
Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to a nutrient pharmaceutical formulation and its use for the treatment of cancer. More specifically, the present invention relates to polyphenol containing pharmaceutical formulations having an effective amount of polyphenols for the treatment of
Tea catechins as cancer specific proliferation inhibitors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
1. INTRODUCTION
The present invention relates to novel methods and compositions for the treatment of primary and metastatic cancers. These methods and compositions utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and
Tea catechins as cancer specific proliferation inhibitors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
1. INTRODUCTION
The present invention relates to novel methods and compositions for the treatment of primary and metastatic cancers. These methods and compositions utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and
Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
1. INTRODUCTION
The present invention relates to novel methods and sustained release compositions which utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and epigallocatechin (EGC), which are found in varying levels in tea
Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable
REFERENCE TO SEQUENCE LISTING, A TABLE, OR A COMPUTER PROGRAM LISTING COMPACT DISK APPENDIX
Not Applicable
BACKGROUND OF THE INVENTION
The present invention relates to novel methods and compositions which utilize
Polyphenol inhibition of nucleoside diphosphate kinase-B activity and cancer metastasis
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of pharmacology and tumor biology. More specifically, the present invention relates to secretion of nucleoside diphosphate kinase (NDPK) from human tumors and the effects of inhibiting
Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
1. INTRODUCTION
The present invention relates to novel methods and compositions which utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and epigallocatechin (EGC), which are found in varying levels in tea leaves, in
(-)-epigallocatechin gallate derivatives for inhibiting proteasome
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to derivates of (-)-epigallocatechin gallate, particularly for use as proteasome inhibitors and/or for inhibition of cancer cell growth.
BACKGROUND OF THE INVENTION
The polyphenols found in green tea extracts are (-)-epicatechin (EC),
(-)-Epigallocatechin gallate derivatives for inhibiting proteasome
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to derivates of (-)-epigallocatechin gallate, particularly for use as proteasome inhibitors and/or for inhibition of cancer cell growth.
BACKGROUND OF THE INVENTION
The polyphenols found in green tea extracts are (-)-epicatechin (EC),
Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumor activity, and method for producing said composition (alternatives)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the National Stage of PCT/RU2013/000568 filed on Jul. 19, 2013, which claims priority under 35 U.S.C. .sctn.119 of Russian Application No. 2012144002 filed on Oct. 16, 2012, the disclosures of which are incorporated by reference. The
Method of treating topical angiogenesis-related disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The invention relates to cosmetic and pharmaceutical treatment methods. More specifically, the invention relates to treatment of angiogenesis-related disorders, particularly skin disorders.
BACKGROUND OF THE INVENTION
Angiogenesis, which is the process of producing new
Methods and compositions for inhibiting 5.alpha.-reductase activity
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to compounds, compositions and methods regulating the actions of androgens and other steroid hormones by modulating the activity of 5.alpha.-reductase. More particularly, the present invention relates to
Polyphenol coxib combinations and methods
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The field of the invention is pharmaceutical agents for treatment and chemoprevention of neoplastic diseases.
BACKGROUND OF THE INVENTION
Green tea extracts and their isolated constituents have been described in numerous reports as antineoplastic agents. For example, U.S. Pat.
Combretastatin A-3 prodrug
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
INTRODUCTION
The present invention relates generally to the field of antineoplastic agents and more particularly to novel and unexpectedly beneficial methods of synthesizing combretastatin A-3 and thereafter converting combretastatin A-3 into a series of diphosphate prodrugs containing an anion
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
